Crossmark

Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4−/− mouse and bipolar cells in the rd1 mouse and human retina ex vivo

Crossref DOI link: https://doi.org/10.1038/gt.2016.54

Published Online: 2016-07-14

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Silva, S R

Charbel Issa, P

Singh, M S

Lipinski, D M

Barnea-Cramer, A O

Walker, N J

Barnard, A R

Hankins, M W

MacLaren, R E
License Information

Text and Data Mining valid from 2016-07-14

Version of Record valid from 2016-07-14
More Information

Article History

Received: 19 October 2015

Revised: 12 April 2016

Accepted: 20 April 2016

First Online: 14 July 2016

Competing interests

: REM is a Founder and Director of Nightstarx Ltd (Gibbs Building, 215 Euston Road, London NW1 2BE), a choroideremia gene therapy company established by the University of Oxford and funded by the Wellcome Trust through Syncona Partners.

Document is current

Any future updates will be listed below